• NWOW
    Categories:

    New Ways of Working in a new era: EORTC new hybrid work model based on collaboration and flexibility

  • Researchers collaborating
    Categories:

    Independent Clinical Cancer Research in the Continuum of Drug Development into Access – for Patient-Centred Cancer Treatment & Care

  • Lung
    Categories: ,

    KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disease-Free Survival Versus Placebo as Adjuvant Treatment for Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless of PD-L1 Expression

  • Biomedical alliance in Europe
    Categories:

    EHDS: an opportunity to unleash the power of data?

  • Categories:

    Save and improve citizens’ lives across Europe by continuing vital EU-UK research collaboration

  • Categories:

    Opportunity with Neoplasia journal – Commissioning Editor Oncology (call for applications)

  • Biostatistics

    Results from monotherapy group in UPSTREAM demonstrate trial’s feasibility in head and neck squamous cell carcinoma

  • RTF Banner

    EORTC TOLERANCE trial in elderly patients with advanced soft tissue sarcoma receives support from Rising Tide Foundation